- Antibody production after SARS-CoV2 vaccination and COVID-19 incidence in liver transplant recipients
-
Masano Y, Ito T, Aoki H, Hirata M, Okumura S, Anazawa T, Nagai K, Hata K, Hatano E
- KMID: 2535285
- Korean J Transplant.
- 2022 Nov;36(Supple 1):S220.
- doi: 10.4285/ATW2022.F-3568
Background: Organ transplant recipients are immunocompromised and at high risk for COVID-19. In the present study, we investigated the antibody production after SARS-CoV2 vaccination and COVID-19 incidence in liver transplant... -
- CITED
-
- Close
- SHARE
-
- Close
